ArticleCureus2026
Right Ventricular Pacing as Rescue Therapy for Cardiogenic Shock in Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Takotsubo cardiomyopathy (TC) is a disease characterized by chest pain that must be differentiated from acute coronary syndrome, yet the coronary arteries are normal, and left ventricular systolic function is impaired. Historically, it had been recognized as a disease with a relatively favorable prognosis that improved spontaneously, but recent reports have made it clear that this is not necessarily the case. Particularly challenging situations arise when left ventricular outflow tract obstruction (LVOTO) is present, and this tendency is especially pronounced when accompanied by cardiogenic shock. In such cases, beta-agonists and nitrates are contraindicated, and beta-blockers cannot be used due to hypotension, leaving limited treatment options. This report describes the first successful treatment of cardiogenic shock due to TC with LVOTO using right ventricular (RV) pacing. A 79-year-old woman presented with chest pain; coronary angiography was normal. She subsequently developed cardiogenic shock. Echocardiography revealed akinesis from the apex to the septum, hyper-contraction at the base, severe LVOTO with associated systolic anterior movement of the mitral anterior leaflet, leading to mitral regurgitation. Peak pressure gradient (PG) was 160 mmHg in the left ventricular outflow tract, and an ejection fraction (EF) was 30%. Despite fluid therapy and norepinephrine administration, there was little improvement, and systolic blood pressure dropped to 60 mmHg. Upon initiating emergency temporary RV pacing, systolic blood pressure rose from 68 mmHg to 98 mmHg, and the left ventricular outflow tract PG decreased from 160 mmHg to 107 mmHg. Basal hyper-contractility also decreased. On the following day, a permanent dual-chamber pacemaker was implanted to achieve atrioventricular synchrony, leading to further stabilization of hemodynamics. By day 21, cardiac function normalized (EF 60%, PG 7 mmHg). The acetylcholine stress test ruled out coronary vasospastic angina. We diagnosed this patient with TC with LVOTO. The patient was discharged in good condition. Intentional induction of left ventricular desynchrony via RV pacing reduced hyper-contractility, rapidly lessened LVOTO, and facilitated recovery from cardiogenic shock. To the best of our knowledge, this is the first report demonstrating the efficacy of RV pacing in shock patients with TC complicated by LVOTO. In this highly critical situation, it may provide an easily accessible and clinically useful treatment option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.